All In Biotech

Free tool

FAERS Monitor: Rizafilm

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205394 or its brand name (Rizafilm, Rizatriptan Benzoate). Reports on generic versions are filed under their own applications.

Reports

1,646

Serious

1,034

63% of reports

Hospitalization

358

Death reported

34

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective420
  • headache259
  • off label use247
  • nausea239
  • migraine204
  • product use in unapproved indication178
  • drug intolerance175
  • hypersensitivity169
  • fatigue140
  • swelling face132
  • angioedema128
  • dysphonia128
  • swollen tongue128
  • drug ineffective for unapproved indication121
  • diarrhoea107

Reports by year received

View as table
YearReports
20044
20057
20063
200721
200831
200928
201015
201120
201215
201342
201436
201532
201665
201761
201896
2019131
2020113
2021118
2022159
2023152
2024166
2025189
2026142

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,513 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
swollen tongueSignal12852.644.56,408
angioedemaSignal12837.131.44,454
drug ineffective for unapproved indicationSignal12128.223.83,153
dysphoniaSignal12828.023.73,310
migraineSignal20427.424.15,168
swelling faceSignal13226.022.03,146
drug intoleranceSignal17523.220.23,704
hypersensitivitySignal16911.610.11,647
product use in unapproved indicationSignal1789.28.01,304
headacheSignal2595.34.7922
drug ineffectiveSignal4204.13.81,035
nauseaSignal2393.93.4523
off label useSignal2473.63.2482
fatigueSignal1402.32.0105
diarrhoeaSignal1072.11.864

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.